Clinical Trial Update: Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Galinpepimut-S in combination with pembrolizumab in selected advanced cancers (Phase 1/2) with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Colorectal Cancer
• Ovarian Cancer
• Small Cell Lung Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Galinpepimut-S
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Sellas Life Sciences Group | Conditions: Acute Myelogenous Leukemia, Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-11-19